Abstract
Objectives We evaluated determinants of stent geometry in bicuspid valves treated with balloon expandable TAVR.
Background The anatomic substrate of bicuspid valves may lead to suboptimal TAVR stent expansion and geometry.
Methods A multicentre observational registry of patients who underwent post TAVR CT to determine stent area (vs nominal valve area) and stent ellipticity (maximum diameter/minimum diameter). Predictors of relative stent expansion (minimum area/average of inflow + outflow area) and stent ellipticity were evaluated in a multivariable regression model including valve calcium volume, presence of raphe calcium, sinus diameters indexed for area derived annular diameter, and performance of pre-dilation and post-dilation.
Results The registry enrolled 101 patients from 4 centres. Minimum stent area (vs nominal area) was 88.1% and maximum ellipticity was 1.10 with both observed near the midframe of the valve in all cases. Relative stent expansion ≥90% was observed in 64/101 patients. The only significant predictor of relative stent expansion ≥90% was performance of post-dilation (p<0.01). Relative stent expansion ≥90% was seen in 86% of patients with post dilation compared to 57% of without (p<0.001). The stent ellipticity ≥ 1.1 was observed in 47/101 patients. The significant predictors of stent ellipticity ≥1.1 was the presence of raphe calcification (p=0.02) and intercommisural diameter at 4 mm above the annular plane (p=0.004).
Conclusion Relative stent expansion ≥90% was associated with the performance of post-dilation and stent ellipticity was associated with the presence of calcified raphe and sinus dimensions (Intercommisural diameter at 4 mm above the annular plane). Further studies to determine optimal deployment strategies in bicuspid valves are needed.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received for this manuscript
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
HiREB at HHS approved and every center locally got the respective HiREB
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Disclosures: J. Chavarria, J. Velianou, J. Sathananthan, M.K. Natarajan, J D. Wood, N. Fam and T. Sheth have received honorarium and research grant support from Edwards Lifesciences. N. Fam has received grant support Abbott and Cardiovalve. J. Sathananthan is a consultant to Medtronic, Boston Scientific, and Anteris.
Data Availability
The dicom data, and statistics outputs supporting the conclusions of this article will be made available by the authors, without undue reservation.
Abbreviation List
- TAVR
- transcatheter aortic valve replacement
- SAVR
- Surgical aortic valve replacement
- PVL
- paravalvular leak
- CT
- computed tomography
- BEV
- balloon expandable transcatheter aortic valve
- BSA
- body surface area
- BAV
- Bicuspid Aortic Valve
- HALT
- hypoattenuation leaflet thickening